Research location
Montichiari
Italy
Advertisement
Research activity in Montichiari
ItalyCureCurrent currently publishes aggregate city-level research activity for this location: 14 trials and 15 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Montichiari
14 linked trials · page 1 of 1Non-interventional Study of Risperidone ISM® in Schizophrenia Patients Hospitalised Due to a RelapseNCT05480046 · 2022-10-18 · 1 site observation
COMPLETED
A Research Study to Look Into How Semaglutide, Together With a Lower Dose of Insulin Glargine, Compares to a Higher Dose of Insulin Glargine Alone in People With Type 2 Diabetes (SUSTAIN OPTIMIZE)NCT05514535 · 2022-08-29 · 1 site observation
COMPLETED
Comorbidities and Risk Score in COVID-19 PatientsNCT04670094 · 2020-12-30 · 1 site observation
COMPLETED
Study of Evobrutinib in Participants With RMS (evolutionRMS 1)NCT04338022 · 2020-06-12 · 1 site observation
TERMINATED
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple SclerosisNCT02576717 · 2015-10-16 · 1 site observation
COMPLETED
Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®NCT02499900 · 2015-08-10 · 1 site observation
COMPLETED
Tecfidera Slow-Titration StudyNCT02428231 · 2015-04-01 · 1 site observation
TERMINATED
Efficacy and Safety Study of Ozanimod in Relapsing Multiple SclerosisNCT02047734 · 2013-12-03 · 2 site observations
COMPLETED
Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)NCT01963611 · 2013-10-01 · 1 site observation
TERMINATED
Optical Coherence Tomography (OCT) Trial in Multiple SclerosisNCT02907281 · 2012-05-29 · 1 site observation
COMPLETED
Exploratory Study of the Safety, Tolerability and Efficacy of Multiple Regimens of Natalizumab in Adult Participants With Relapsing Multiple Sclerosis (MS)NCT01405820 · 2011-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaNCT01252355 · 2011-01-01 · 1 site observation
TERMINATED
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoNCT00548405 · 2007-10-01 · 1 site observation
COMPLETED
Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension PhaseNCT00340834 · 2006-05-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.